Search research articles
Contact Us
Filters
Showing results (791-800 of 813) with videos related to
Page
of 82
Sort By:
Nature Medicine
|
October 7, 2017
Corrigendum: Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi-Xiao Wang, Yan-Xiao Ji, Xiao-Jing Zhang, et al.
Zhonghua Yi Xue Za Zhi
|
February 17, 2016
[Quadruple regimens using domestically manufactured drugs in gastritis and duodenal ulcer patients for Helicobacter pylori eradication: a perspective, multicenter, randomized controlled trial]
Wen Gao, Fulian Hu, Hong Cheng, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 15, 2025
Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed care
Matthew I Ebia, Anser A Abbas, Abrahm Levi, et al.
Human Vaccines & Immunotherapeutics
|
December 16, 2025
Pre-vaccine immune profiling in cancer patients identifies correlates of COVID-19 vaccine responses
Maryam Kazerani, Simeon Mahov, Joslyn Foley, et al.
Journal of Affective Disorders
|
August 27, 2022
Reliability and validity of the Chinese version of the kiddie-schedule for affective disorders and schizophrenia-present and lifetime version DSM-5 (K-SADS-PL-C DSM-5)
Yue Dun, Qiu-Rong Li, Hui Yu, et al.
Nature Medicine
|
January 2, 2018
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Yan-Xiao Ji, Zan Huang, Xia Yang, et al.
Science (New York, N.Y.)
|
January 17, 2025
Simulating 500 million years of evolution with a language model
Thomas Hayes, Roshan Rao, Halil Akin, et al.
Hepatology Communications
|
June 19, 2024
Development and validation of a biomarker index for HCC treatment response
Jeff Liang, Po-Yi Li, Joshua Norman, et al.
JCO Precision Oncology
|
April 11, 2024
Phase II Study of Erdafitinib in Patients With Tumors With <i>FGFR</i> Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1
Jun Gong, Alain C Mita, Zihan Wei, et al.
JCO Precision Oncology
|
April 11, 2024
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2
Jun Gong, Alain C Mita, Zihan Wei, et al.
Page
of 82
Search research articles
Search
Showing results (791-800 of 813) with videos related to
Sort By:
Page
of 82
Nature Medicine
|
October 7, 2017
Corrigendum: Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi-Xiao Wang, Yan-Xiao Ji, Xiao-Jing Zhang, et al.
Zhonghua Yi Xue Za Zhi
|
February 17, 2016
[Quadruple regimens using domestically manufactured drugs in gastritis and duodenal ulcer patients for Helicobacter pylori eradication: a perspective, multicenter, randomized controlled trial]
Wen Gao, Fulian Hu, Hong Cheng, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 15, 2025
Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed care
Matthew I Ebia, Anser A Abbas, Abrahm Levi, et al.
Human Vaccines & Immunotherapeutics
|
December 16, 2025
Pre-vaccine immune profiling in cancer patients identifies correlates of COVID-19 vaccine responses
Maryam Kazerani, Simeon Mahov, Joslyn Foley, et al.
Journal of Affective Disorders
|
August 27, 2022
Reliability and validity of the Chinese version of the kiddie-schedule for affective disorders and schizophrenia-present and lifetime version DSM-5 (K-SADS-PL-C DSM-5)
Yue Dun, Qiu-Rong Li, Hui Yu, et al.
Nature Medicine
|
January 2, 2018
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Yan-Xiao Ji, Zan Huang, Xia Yang, et al.
Science (New York, N.Y.)
|
January 17, 2025
Simulating 500 million years of evolution with a language model
Thomas Hayes, Roshan Rao, Halil Akin, et al.
Hepatology Communications
|
June 19, 2024
Development and validation of a biomarker index for HCC treatment response
Jeff Liang, Po-Yi Li, Joshua Norman, et al.
JCO Precision Oncology
|
April 11, 2024
Phase II Study of Erdafitinib in Patients With Tumors With <i>FGFR</i> Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1
Jun Gong, Alain C Mita, Zihan Wei, et al.
JCO Precision Oncology
|
April 11, 2024
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2
Jun Gong, Alain C Mita, Zihan Wei, et al.
Page
of 82